Market Cap 762.25M
Revenue (ttm) 105.76M
Net Income (ttm) 12.09M
EPS (ttm) N/A
PE Ratio 195.00
Forward PE 18.57
Profit Margin 11.43%
Debt to Equity Ratio 0.00
Volume 66,000
Avg Vol 257,980
Day's Range N/A - N/A
Shares Out 93.76M
Stochastic %K 94%
Beta 1.72
Analysts Strong Sell
Price Target $20.00

Company Profile

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 619 949 3681
Address:
12770 High Bluff Drive, Suite 150, San Diego, United States
Ayed91
Ayed91 Jun. 21 at 1:52 PM
0 · Reply
topstockalerts
topstockalerts Jun. 17 at 1:45 PM
$GYRE not a bad place for a swing idea 💡💡💡
0 · Reply
Razz_FluidX2
Razz_FluidX2 Jun. 17 at 12:42 PM
0 · Reply
CyrusLopez5
CyrusLopez5 Jun. 16 at 7:49 PM
$AMD $BTC.X $XRP.X $GYRE Analyst price target for today🚀 https://lked.in/options-chat-live
0 · Reply
TwongStocks
TwongStocks Jun. 16 at 12:34 PM
All seven NASDAQ stocks with a RS are being unhalted at 9:00am ET $GCTK 1 for 60. Will reduce outstanding shares from approx 32,541,327 to approx 542,356. $NCI 1 for 5. Will reduce ordinary shares from approx 20.32m to approx 4.064m. $GLYC 1for 100. RS + Merger with Crescent Biopharma. The RS will reduce GLYC ousttanding shares from approx 64.5m to approx 645k. GLYC will then effect the merger with Crescent Bio, changing the ticker to from GLYC to $GYRE. Following the closing of the Merger, the combined company’s total outstanding common stock is expected to be approximately 14.8m shares.
1 · Reply
TwongStocks
TwongStocks Jun. 13 at 8:51 PM
Monday reverse split preview Part 2. $GCTK 1 for 60. Will reduce outstanding shares from approx 32,541,327 to approx 542,356. $NCI 1 for 5. Will reduce ordinary shares from approx 20.32m to approx 4.064m. $GLYC 1for 100. RS + Merger with Crescent Biopharma. The RS will reduce GLYC ousttanding shares from approx 64.5m to approx 645k. GLYC will then effect the merger with Crescent Bio, changing the ticker to from GLYC to $GYRE. Following the closing of the Merger, the combined company’s total outstanding common stock is expected to be approximately 14.8m shares.
1 · Reply
PenkeTrading
PenkeTrading Jun. 12 at 2:34 AM
I found you a Bearish Engulfing Candle Pattern on the daily chart of Gyre Therapeutics Inc.. $GYRE #Gyre #BearishEngulfingCandle #NASDAQ
0 · Reply
jdlman
jdlman Jun. 10 at 4:38 PM
$GYRE why is this scrolling up? Any news ?
0 · Reply
Magic8BallResponse
Magic8BallResponse Jun. 10 at 12:43 PM
$GLYC Need to see where $GYRE opens
0 · Reply
ZacksResearch
ZacksResearch Jun. 6 at 1:33 PM
$GLYC stockholders just approved a 1-for-100 reverse split and a full-on merger 🚨 🧬 GlycoMimetics is merging with Crescent Biopharma and rebranding to "Crescent Biopharma, Inc." with ticker $GYRE 📉 Outstanding shares dropping from 64.5M to just 0.6M 🔁 New shares expected to begin trading June 16 on a post-split basis Massive reset in the works — dilution risk out, fresh story in. See the complete stock outlook here👉 https://www.zacks.com/stock/quote/GLYC?cid=sm-stocktwits-0-quote_overview-oc&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC
0 · Reply
Latest News on GYRE
Ayed91
Ayed91 Jun. 21 at 1:52 PM
0 · Reply
topstockalerts
topstockalerts Jun. 17 at 1:45 PM
$GYRE not a bad place for a swing idea 💡💡💡
0 · Reply
Razz_FluidX2
Razz_FluidX2 Jun. 17 at 12:42 PM
0 · Reply
CyrusLopez5
CyrusLopez5 Jun. 16 at 7:49 PM
$AMD $BTC.X $XRP.X $GYRE Analyst price target for today🚀 https://lked.in/options-chat-live
0 · Reply
TwongStocks
TwongStocks Jun. 16 at 12:34 PM
All seven NASDAQ stocks with a RS are being unhalted at 9:00am ET $GCTK 1 for 60. Will reduce outstanding shares from approx 32,541,327 to approx 542,356. $NCI 1 for 5. Will reduce ordinary shares from approx 20.32m to approx 4.064m. $GLYC 1for 100. RS + Merger with Crescent Biopharma. The RS will reduce GLYC ousttanding shares from approx 64.5m to approx 645k. GLYC will then effect the merger with Crescent Bio, changing the ticker to from GLYC to $GYRE. Following the closing of the Merger, the combined company’s total outstanding common stock is expected to be approximately 14.8m shares.
1 · Reply
TwongStocks
TwongStocks Jun. 13 at 8:51 PM
Monday reverse split preview Part 2. $GCTK 1 for 60. Will reduce outstanding shares from approx 32,541,327 to approx 542,356. $NCI 1 for 5. Will reduce ordinary shares from approx 20.32m to approx 4.064m. $GLYC 1for 100. RS + Merger with Crescent Biopharma. The RS will reduce GLYC ousttanding shares from approx 64.5m to approx 645k. GLYC will then effect the merger with Crescent Bio, changing the ticker to from GLYC to $GYRE. Following the closing of the Merger, the combined company’s total outstanding common stock is expected to be approximately 14.8m shares.
1 · Reply
PenkeTrading
PenkeTrading Jun. 12 at 2:34 AM
I found you a Bearish Engulfing Candle Pattern on the daily chart of Gyre Therapeutics Inc.. $GYRE #Gyre #BearishEngulfingCandle #NASDAQ
0 · Reply
jdlman
jdlman Jun. 10 at 4:38 PM
$GYRE why is this scrolling up? Any news ?
0 · Reply
Magic8BallResponse
Magic8BallResponse Jun. 10 at 12:43 PM
$GLYC Need to see where $GYRE opens
0 · Reply
ZacksResearch
ZacksResearch Jun. 6 at 1:33 PM
$GLYC stockholders just approved a 1-for-100 reverse split and a full-on merger 🚨 🧬 GlycoMimetics is merging with Crescent Biopharma and rebranding to "Crescent Biopharma, Inc." with ticker $GYRE 📉 Outstanding shares dropping from 64.5M to just 0.6M 🔁 New shares expected to begin trading June 16 on a post-split basis Massive reset in the works — dilution risk out, fresh story in. See the complete stock outlook here👉 https://www.zacks.com/stock/quote/GLYC?cid=sm-stocktwits-0-quote_overview-oc&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC
0 · Reply
Jutski_bipolar
Jutski_bipolar Jun. 2 at 8:54 PM
$GYRE dog 🐕 share
0 · Reply
ilcail
ilcail May. 28 at 2:19 AM
what do you think about MASH in China via $GYRE?
0 · Reply
kshonstocks
kshonstocks May. 27 at 9:36 PM
@ripztrip Don't like seeing it here below the 50 dma $GYRE
0 · Reply
umekuri
umekuri May. 27 at 2:40 PM
$GYRE 15~20$ here we go! https://www.gyretx.com/?l-id=mem_pc_foreign_us-stk-corporatetab_corporateinfo
0 · Reply
patb99
patb99 May. 27 at 2:14 PM
$GYRE same as last friday, from 11$ to 8$
1 · Reply
topstockalerts
topstockalerts May. 27 at 2:13 PM
Morning Top Gainers PT2 $ARQQ $ZENA $ETWO $GYRE $CETX
0 · Reply
ripztrip
ripztrip May. 27 at 11:22 AM
$CAPR @Kingjake26 wanted to get your thoughts on $GYRE have a look today, thanks.
2 · Reply
ripztrip
ripztrip May. 26 at 4:51 PM
$GYRE Marking here when you can have gotten in cheap under $9. $2-4 billion in revenues over 5-7 years?
0 · Reply
ripztrip
ripztrip May. 26 at 4:28 PM
@Channelchek what are your targets $GYRE with recent offering and p3 updates?
0 · Reply
ripztrip
ripztrip May. 26 at 4:15 PM
@Kingjake26 @OKLM250 Jake, have a look at $GYRE wanted to get your opinion.
0 · Reply
ripztrip
ripztrip May. 23 at 4:22 PM
$GYRE wow. wild numbers for China and the US. this is worth much more than what it is trading at now? WTH! $PFE $GILD
1 · Reply